Hello,
How are you guys filing drug substance assay method revisions that change from HPLC to UPLC? CBE-30?
What is the rationale?
Cindy
------------------------------
Cindy Lombardy
Sr. Director, Regulatory Affairs
B. Braun Medical Inc.
Ringoes NJ
United States
------------------------------